Effectiveness of rituximab for the otolaryngologic manifestations of granulomatosis with polyangiitis (Wegener's) Academic Article Article uri icon

Overview

MeSH Major

  • Drug Design
  • Lymphoma, B-Cell
  • Lymphoma, Large B-Cell, Diffuse

abstract

  • RTX is an effective treatment for ENT manifestations of GPA. Subjects treated with RTX were significantly less likely to have active ENT disease compared with those not receiving RTX. Patients being treated with RTX were 11 times less likely to have active ENT disease than patients being treated with other therapies.

publication date

  • January 2014

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1002/acr.22311

PubMed ID

  • 25299002

Additional Document Info

start page

  • 1403

end page

  • 9

volume

  • 66

number

  • 9